- Feb 24, 2001
- 17,835
- 3,995
- 113
- School/Org
- University of Michigan Medical School
- City
- Lake Oswego
- State
- OR
Lecturer: @Stuart Richer
Synopsis:
We review how to identify the “high risk AMD patient” , the actual data within the JAMA publications and what it tells us about prevention of catastrophic vision loss in patients who have high risk of developing AMD. Next we explore what to tell the 90 % of patients who don’t have high risk AMD, yet are loosing vision from mild and moderate AMD that effects their night driving and overall visual performance. We explore Level 2 science about mesozeaxanthin and new instrumentation that are enhancing and invigorating the practice of optometry.
Register for CEwire2015 to listen to the recorded lecture & get CE Credit through August 17, 2015.
Discuss the lecture in the thread below.
Synopsis:
We review how to identify the “high risk AMD patient” , the actual data within the JAMA publications and what it tells us about prevention of catastrophic vision loss in patients who have high risk of developing AMD. Next we explore what to tell the 90 % of patients who don’t have high risk AMD, yet are loosing vision from mild and moderate AMD that effects their night driving and overall visual performance. We explore Level 2 science about mesozeaxanthin and new instrumentation that are enhancing and invigorating the practice of optometry.
Register for CEwire2015 to listen to the recorded lecture & get CE Credit through August 17, 2015.
Discuss the lecture in the thread below.
